Cardiac histone acetylation – therapeutic opportunities abound
- 30 April 2004
- journal article
- review article
- Published by Elsevier BV in Trends in Genetics
- Vol. 20 (4), 206-213
- https://doi.org/10.1016/j.tig.2004.02.002
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Inactivation of the Myocyte Enhancer Factor-2 Repressor Histone Deacetylase-5 by Endogenous Ca2//Calmodulin-dependent Kinase II Promotes Depolarization-mediated Cerebellar Granule Neuron SurvivalJournal of Biological Chemistry, 2003
- Direct Interaction of Ca2+/Calmodulin Inhibits Histone Deacetylase 5 Repressor Core Binding to Myocyte Enhancer Factor 2Published by Elsevier BV ,2003
- Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2Nature, 2003
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- The Transcriptional Co-activators CREB-binding Protein (CBP) and p300 Play a Critical Role in Cardiac Hypertrophy That Is Dependent on Their Histone Acetyltransferase ActivityPublished by Elsevier BV ,2003
- The Transcription Factors GATA4 and dHAND Physically Interact to Synergistically Activate Cardiac Gene Expression through a p300-dependent MechanismJournal of Biological Chemistry, 2002
- Expression of TR Isoforms in Failing Human HeartJournal of Clinical Endocrinology & Metabolism, 2001
- dSIR2 and dHDAC6: Two Novel, Inhibitor-Resistant Deacetylases in Drosophila melanogasterExperimental Cell Research, 2001
- The CREB-binding Protein (CBP) Cooperates with the Serum Response Factor for Transactivation of the c-fos Serum Response ElementJournal of Biological Chemistry, 1997
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990